Two Sigma Securities, LLC Biogen Inc. Put Options Transaction History

Two Sigma Securities, LLC

$8.19 Billion
Q2 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $1.94 Million - $2.41 Million	-10,200 Reduced 44.35%	12,800 $2.97 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $4.33 Million - $5.46 Million	20,400 Added 784.62%	23,000 $4.96 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $422,921 - $509,086	-1,900 Reduced 42.22%	2,600 $672,000
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $759,900 - $857,670	3,000 Added 200.0%	4,500 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $412,875 - $477,090	1,500 New	1,500 $427,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $2.23 Million - $2.65 Million	11,900 Added 133.71%	20,800 $4.24 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.22 Million - $1.54 Million	6,300 Added 242.31%	8,900 $1.87 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $283,512 - $426,756	1,200 Added 85.71%	2,600 $637,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $3.89 Million - $4.49 Million	-14,700 Reduced 91.3%	1,400 $397,000
Q2 2020 Sep 10, 2020	BUY	$258.66 - $342.55 $3.91 Million - $5.17 Million	15,100 Added 1510.0%	16,100 $4.31 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $4.3 Million - $5.46 Million	-16,000 Reduced 94.12%	1,000 $316,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $154,042 - $212,849	-700 Reduced 3.95%	17,000 $5.04 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $3.6 Million - $3.96 Million	16,400 Added 1261.54%	17,700 $4.14 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $1.02 Million - $1.59 Million	-4,700 Reduced 78.33%	1,300 $307,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $10.3 Million - $13 Million	-36,900 Reduced 86.01%	6,000 $1.81 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.58 Million - $3.38 Million	8,800 Added 25.81%	42,900 $15.2 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2.24 Million - $2.67 Million	8,700 Added 34.25%	34,100 $9.9 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $6.61 Million - $9.34 Million	25,400 New	25,400 $6.96 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account